InVivo Therapeutics competitors

InVivo Therapeutics Competitors include NeuralStem, Brainstorm Cell Therapeutics, Semma Therapeutics, ACADIA Pharmaceuticals and Diasome.
Add company...
InVivo Therapeutics
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
NeuralStem
NeuralStem
NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.
Semma Therapeutics
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Diasome
Diasome
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
Founding Date
Founding Date
2005
Founding Date
1996
Founding Date
2004
Founding Date
2015
Founding Date
1993
Founding Date
2004
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Rockville, US HQ
Locations
Hackensack, US HQ
Holon, IL
Locations
Cambridge, US HQ
Providence, US
Locations
San Diego, US HQ
Locations
Cleveland, US HQ
Employees
Employees
37
Employees
11
Employees
1726% decrease
Employees
506% increase
Employees
42515% increase
Employees
8
Valuation ($)
Valuation ($)
18.9 m
Valuation ($)
7.7 m
Valuation ($)
65.8 m
Valuation ($)
N/A
Valuation ($)
2.3 b
Valuation ($)
N/A
Twitter followers
Twitter followers
1.2 k
Twitter followers
2.2 k
Twitter followers
703
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
62

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$260k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$124.9m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($26.7m) (FY, 2017)
Net income
($15.7m) (FY, 2017)
Net income
($5m) (FY, 2017)
Net income
N/A
Net income
($289.4m) (FY, 2017)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 114m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 30m (over 1 year ago)
Total funding raised
Total funding raised
$ 75.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 163m
Total funding raised
N/A
Total funding raised
$ 42.9m
For sources of this data, please see the company profileDownload Excel

View company profiles

NeuralStem
HQ
Rockville, US
Employees
11

NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.

View company
Brainstorm Cell Therapeutics
HQ
Hackensack, US
Employees
17↓ 26% decrease

BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.

View company
Semma Therapeutics
HQ
Cambridge, US
Employees
50↑ 6% increase

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

View company
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
425↑ 15% increase

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

View company